SWM
GMAB icon

Sanctuary Wealth Management’s Genmab GMAB Stock Holding History

Sanctuary Wealth Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-35
Closed -$1.05K – 275
2024
Q1 		$1.05K Hold
35
– – ﹤0.01% 232
2023
Q4 		$1.11K Hold
35
– – ﹤0.01% 239
2023
Q3 		$1.23K Hold
35
– – ﹤0.01% 220
2023
Q2 		$1.33K Buy
+35
New +$1.4K ﹤0.01% 226
2022
Q4 		$1.48K Buy
+35
New +$1.44K ﹤0.01% 199

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanctuary Wealth Management's GMAB Position: Q2 2024 in Review

Sanctuary Wealth Management sold out of Genmab (GMAB) in Q2 2024, closing a stake of 35 shares — an estimated $1.05K sold.

Sanctuary Wealth Management first reported a position in GMAB in Q4 2022 and held it in 5 quarters. The position peaked at $1.48K in Q4 2022. 219 funds tracked by Wall St. Rank hold GMAB as of Q2 2024.

  • Sanctuary Wealth Management reported no remaining Genmab position as of Q2 2024 after selling out during the quarter.
  • Sanctuary Wealth Management sold 35 Genmab shares in Q2 2024, an estimated $1.05K.
  • Sanctuary Wealth Management first reported a position in Genmab in Q4 2022 and held it in 5 quarters.
  • Sanctuary Wealth Management's Genmab position peaked at $1.48K in Q4 2022.
  • 219 funds tracked by Wall St. Rank held Genmab as of Q2 2024.

Based on Sanctuary Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.